ENFN - Enfusion Q2 GAAP EPS revenue beats guidance in-line with consensus
- Enfusion press release ( NYSE: ENFN ): Q2 GAAP EPS of -$0.03 beats by $0.01 .
- Revenue of $36.5M (+38.0% Y/Y) beats by $0.92M .
- For Q3, revenue is expected to be in the range of $38M to $39M (vs. consensus of $38.59M).
- For FY22, revenue is expected to be in the range of $149.3M to $152.3M (vs. consensus of $149.89M)
For further details see:
Enfusion Q2 GAAP EPS, revenue beats, guidance in-line with consensus